vadimezan has been researched along with bx795 in 1 studies
| Studies (vadimezan) | Trials (vadimezan) | Recent Studies (post-2010) (vadimezan) | Studies (bx795) | Trials (bx795) | Recent Studies (post-2010) (bx795) |
|---|---|---|---|---|---|
| 272 | 16 | 101 | 57 | 0 | 53 |
| Protein | Taxonomy | vadimezan (IC50) | bx795 (IC50) |
|---|---|---|---|
| 3-phosphoinositide-dependent protein kinase 1 | Homo sapiens (human) | 0.006 | |
| NUAK family SNF1-like kinase 1 | Homo sapiens (human) | 0.005 | |
| Serine/threonine-protein kinase ULK1 | Homo sapiens (human) | 0.087 | |
| Inhibitor of nuclear factor kappa-B kinase subunit epsilon | Homo sapiens (human) | 0.0295 | |
| [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial | Homo sapiens (human) | 0.065 | |
| Serine/threonine-protein kinase ULK2 | Homo sapiens (human) | 0.31 | |
| Cyclic GMP-AMP synthase | Homo sapiens (human) | 0.06 | |
| Serine/threonine-protein kinase TBK1 | Homo sapiens (human) | 0.0163 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mikek, CG; Sintim, HO; Sooreshjani, MA; Wang, M | 1 |
1 review(s) available for vadimezan and bx795
| Article | Year |
|---|---|
Interrupting cyclic dinucleotide-cGAS-STING axis with small molecules.
Topics: | 2019 |